Evolution of an inhibin A ELISA method: Implications for Down's syndrome screening

Annals of Clinical Biochemistry

Volumn 35, Issue 5, 1998, Pages 656-664

  Wallace, E M ^a   Crossley, J A ^b   Ritoe, S C ^c   Aitken, D A ^b   Spencer, K ^d   Groome, N P ^e  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d OLDCHURCH HOSPITAL   (United Kingdom)

^e OXFORD BROOKES UNIVERSITY   (United Kingdom)

Author keywords

Immunoassay; Pregnancy; Prenatal screening; Trisomy 21

Indexed keywords

DODECYL SULFATE SODIUM; INHIBIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH CARE COST; HUMAN; HUMAN CELL; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; TEMPERATURE; TRISOMY 21;

EID: 0031718879     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500510     Document Type: Article

References (26)

1. Wallace EM, Grant VE, Swanston IA, Groome NP. Evaluation of maternal serum dimeric inhibin A as a first trimester marker of Down's syndrome. Prenat Diagn 1995; 15: 359-62
2. Cuckle HS, Holding S, Jones R, Wallace EM, Groome NP. Maternal serum dimeric inhibin A in second trimester Down's syndrome pregnancies. Prenat Diagn 1995; 15: 385-6
3. Wallace EM, Swanston IA, McNeilly AS, Ashby JP, Blundell G, Calder AA, et al. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. Clin Endocrinol 1996; 44: 17-21
4. Aitken DA, Wallace EM, Crossley JA, Swanston IA, van Pareren Y, van Maarle M, et al. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. N Engl J Med 1996; 334: 1321-6
5. Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. Combining inhibin with existing second trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 1996; 16: 1095-101
6. Spencer K, Ritoe SC, Wallace EM. Second trimester dimeric inhibin A in Down's syndrome screening. Prenat Diagn 1996; 16: 1101-10
7. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin A as a serum marker. Prenat Diagn 1996; 16: 143-53
8. Noble PL. Wallace EM, Snijders RJM, Groome NP. Nicolaides KH. Maternal serum inhibin A and free β-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation. Br J Obstet Gynaecol 1997; 104: 367-71
9. Groome NP, O'Brien M. Two-site immunoassays for inhibin and its subunits. Further applications of the synthetic peptidc approach. J Immunol Methods 1993; 165: 167-76
10. Wallace EM, Riley SC, Crossley JA, Ritoe SC, Home A, Shade M, et al. Dimeric inhibins in amniotic fluid, maternal serum and fetal serum in human pregnancy. J Clin Endocrinol Metab 1997; 82: 218-22
11. Groome NP, Illingworth PJ, O'Brien M, Cooke I, Ganeson TS, Baird DT, et al. Detection of dimeric inhibin throughout the menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994; 40: 717-23
12. Knight PG, Muttukrishna S. Measurement of dimeric inhibin using a modified two-site immunoradiometric assay specific for oxidised (Met O) inhibin. J Endocrinol 1994; 141: 417-25
13. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather J, et al. Measurement of dimeric inhibin-B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 81: 1401-5
14. Knight PG, Muttukrishna S, Groome NP. Development and application of a two site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol 1996; 148: 267-79
15. Cuckle HS, Wald NJ, Thompson S. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and maternal serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387-402
16. Schneyer AL, Mason AJ, Burton LE, Zeigner JR, Crowley WF Jr. Immunoreactive inhibin α-subunit in human serum: Implications for radioimmunoassay. J Clin Endocrinol Metab 1990; 70: 1208-12
17. Robertson DM, Sullivan J, Cahir N. Inhibin forms in human plasma. J Endocrinol 1995; 144: 261-9
18. Robertson D, Burger HG, Sullivan J, Cahir N, Groome N, Poncelet E, et al. Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab 1996; 81: 669-76
19. Robertson DM, Cahir N, Findlay JK, Burger HCJ, Groome N. The biological and immunological characterization of inhibin A and B forms in human follicular fluid and plasma. J Clin Endocrinol Metab 1997; 82: 889-96
20. Mason AJ, Farnworth PG, Sullivan J. Characterization and determination of the biological activities of non-cleavable high molecular weight forms of inhihin A and activin A. Mol Endocrinol 1996; 10: 1055-65
21. Good TEM, Weber PSD, Ireland JLH, Pulaski J, Padmanabhan V, Schneyer AL, et al. Isolation of nine different biologically and immunologically active molecular variants of bovine follicular inhibin. Biol Reprod 1995; 53: 1478-88
22. Priddle JD, O'Brien M, Groome NP. Purification and quantitation of high molecular weight precursors of human inhibin [abstract P3-516]. In: Proceedings of the 77th Annual Meeting of the Endocrine Society, Jun 14-17, 1995. Washington DC. Washington DC: The Endocrine Society, 1995
23. Kardana A, Cole LA. The stability of hCG and free beta-subunit in serum samples. Prenat Diagn 1997; 17: 141-7
24. Wallace EM, Healy DL. Inhibins and activins: roles in clinical practice. Br J Obstet Gynaecol 1996; 103: 945-56
25. Wallace EM, Crossley JA, Ritoe S, Groome NP, Aitken DA. Inhibin A in amniotic fluid in chromosomally normal and Down's syndrome pregnancies. J Endocrinol 1997; 152: 109-12
26. Rose MP, Gaines-Das RE. International collaborative study by in vitro bioassays and immunoassays of the first international standard for inhibin, human recombinant. Biologicals 1996; 24: 1-24